Make-up of HSE clinical review team dogged by controversy

Considering the contentious nature of the case, it is perhaps unsurprising that even the make-up of the HSE “clinical review” into Savita Halappanavar’s death has repeatedly been dogged by controversy.

Make-up of HSE clinical review team dogged by controversy

From questions over the review chairman’s background to the removal of half of the team due to claims of potential bias, the 108-page report has faced hurdles even outside uncovering the facts of the case.

The inquiry was chaired by Prof Sabaratnam Arulkumaran who has a stellar background in obstetrics and gynaecology.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited